Edwards Lifesciences news
The WiseView Research desk's stories that name Edwards Lifesciences, the latest headlines about it, and the trades members of Congress and company insiders have disclosed. The EW page →
- HeadlineIs This the Right Time to Hold EW Stock in Your Portfolio?
- HeadlineEdwards Lifesciences to Host Earnings Conference Call on November 4, 2026
- HeadlineEdwards Lifesciences to Host Investor Event in Conjunction With TCT
- HeadlineEdwards Lifesciences Receives FDA Approval for AUTUS Valve, the First Surgical Pulmonary Valve for Pediatric Patients
- CongressRo Khanna bought $1,001 - $15,000 of EW
- CongressJosh Gottheimer sold $1,001 - $15,000 of EW
- CongressRo Khanna sold $1,001 - $15,000 of EW
- CongressBruce Westerman sold $1,001 - $15,000 of EW
- CongressJefferson Shreve bought $15,001 - $50,000 of EW
- CongressRob Bresnahan bought $1,001 - $15,000 of EW
- CongressBruce Westerman bought $1,001 - $15,000 of EW
Headlines link to their publishers. Members of Congress disclose ranges, not exact amounts, and may file weeks after the trade; insider filings are open-market purchases and sales from SEC Form 4. For information only, not investment advice.